Literature DB >> 31427825

Optimal designs for frequentist model averaging.

K Alhorn1, K Schorning2, H Dette2.   

Abstract

We consider the problem of designing experiments for estimating a target parameter in regression analysis when there is uncertainty about the parametric form of the regression function. A new optimality criterion is proposed that chooses the experimental design to minimize the asymptotic mean squared error of the frequentist model averaging estimate. Necessary conditions for the optimal solution of a locally and Bayesian optimal design problem are established. The results are illustrated in several examples, and it is demonstrated that Bayesian optimal designs can yield a reduction of the mean squared error of the model averaging estimator by up to 45%.

Entities:  

Keywords:  Bayesian optimal design; Local misspecification; Model averaging; Model selection; Model uncertainty; Optimal design

Year:  2019        PMID: 31427825      PMCID: PMC6690170          DOI: 10.1093/biomet/asz036

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   3.028


  11 in total

1.  Modeling of the bacterial growth curve.

Authors:  M H Zwietering; I Jongenburger; F M Rombouts; K van 't Riet
Journal:  Appl Environ Microbiol       Date:  1990-06       Impact factor: 4.792

2.  Innovative approaches for designing and analyzing adaptive dose-ranging trials.

Authors:  Björn Bornkamp; Frank Bretz; Alex Dmitrienko; Greg Enas; Brenda Gaydos; Chyi-Hung Hsu; Franz König; Michael Krams; Qing Liu; Beat Neuenschwander; Tom Parke; José Pinheiro; Amit Roy; Rick Sax; Frank Shen
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

Review 3.  The Hill equation: a review of its capabilities in pharmacological modelling.

Authors:  Sylvain Goutelle; Michel Maurin; Florent Rougier; Xavier Barbaut; Laurent Bourguignon; Michel Ducher; Pascal Maire
Journal:  Fundam Clin Pharmacol       Date:  2008-12       Impact factor: 2.748

Review 4.  Dose finding - a challenge in statistics.

Authors:  Frank Bretz; Jason Hsu; José Pinheiro; Yi Liu
Journal:  Biom J       Date:  2008-08       Impact factor: 2.207

Review 5.  Viewpoint: model selection uncertainty, pre-specification, and model averaging.

Authors:  Björn Bornkamp
Journal:  Pharm Stat       Date:  2015-01-16       Impact factor: 1.894

6.  Model selection versus model averaging in dose finding studies.

Authors:  Kirsten Schorning; Björn Bornkamp; Frank Bretz; Holger Dette
Journal:  Stat Med       Date:  2016-05-25       Impact factor: 2.373

7.  Practical considerations for optimal designs in clinical dose finding studies.

Authors:  Frank Bretz; Holger Dette; Jose C Pinheiro
Journal:  Stat Med       Date:  2010-03-30       Impact factor: 2.373

8.  Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models.

Authors:  Simon Buatois; Sebastian Ueckert; Nicolas Frey; Sylvie Retout; France Mentré
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

Review 9.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

10.  Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection.

Authors:  Yasunori Aoki; Daniel Röshammar; Bengt Hamrén; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-04       Impact factor: 2.745

View more
  1 in total

1.  Active Inferants: An Active Inference Framework for Ant Colony Behavior.

Authors:  Daniel Ari Friedman; Alec Tschantz; Maxwell J D Ramstead; Karl Friston; Axel Constant
Journal:  Front Behav Neurosci       Date:  2021-06-24       Impact factor: 3.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.